Keyphrases
Liraglutide
89%
Confidence Interval
66%
Aortic Stenosis
59%
N-terminal Pro-brain Natriuretic Peptide (NT-proBNP)
59%
Hazard Ratio
55%
Placebo-controlled
54%
Simvastatin
46%
Randomized Double-blind
46%
Type 2 Diabetes Mellitus (T2DM)
46%
Ezetimibe
46%
Hypokalemia
44%
Glucagon-like
43%
All-cause Mortality
42%
Heart Failure
41%
Atrial Fibrillation
39%
Patients with Coronary Artery Disease
39%
Stable Coronary Artery Disease
39%
Coronary Artery Disease
34%
Myocardial Infarction
33%
New-onset Type 2 Diabetes
33%
Middle-aged
33%
Aortic Valve Stenosis
33%
Overall Mortality
31%
Placebo
31%
Metformin
30%
Positive Airway Pressure Therapy
29%
High-sensitivity C-reactive Protein (hs-CRP)
29%
Faroe Islands
29%
Carnitine Deficiency
29%
Sleep Apnea
29%
Community-dwelling
29%
Strong Predictor
29%
A1 Receptor
26%
Receptor Agonist
26%
Type 2 Diabetic Patients
26%
Screening Program
22%
Stroke Risk
21%
Ectopic Activity
21%
Moderate to Severe
21%
Severe Aortic Stenosis
21%
β-cell Function
20%
Left Ventricular Ejection Fraction
20%
Prognostic Significance
20%
Heart Rate
19%
Ventricular Arrhythmia
18%
Aortic Valve Area
18%
Heart Rate Variability
18%
Systolic Function
18%
Insulin Sensitivity
18%
Nationwide Screening
18%
Pharmacology, Toxicology and Pharmaceutical Science
Coronary Artery Disease
100%
Liraglutide
74%
Non Insulin Dependent Diabetes Mellitus
63%
Congestive Heart Failure
62%
Placebo
62%
Brain Natriuretic Peptide
55%
Cerebrovascular Accident
52%
Aortic Stenosis
44%
Hypokalemia
44%
Aortic Valve Stenosis
42%
All Cause Mortality
39%
Cohort Study
33%
Troponin T
29%
Heart Infarction
27%
Glucagon Like Peptide 1 Receptor Agonist
24%
Simvastatin
22%
Ezetimibe
22%
C Reactive Protein
22%
Atrial Fibrillation
20%
Biological Marker
19%
Isotopes of Potassium
19%
Ezetimibe Plus Simvastatin
16%
Diseases
16%
Thorax Pain
15%
Metformin
15%
Medicine and Dentistry
Coronary Artery Disease
61%
Liraglutide
59%
Placebo
57%
Congestive Heart Failure
48%
Maturity Onset Diabetes of the Young
44%
Apoplexy
33%
Systolic Function
31%
Hazard Ratio
31%
Blood Pressure
30%
Aortic Stenosis
29%
Coronary Computed Tomography Angiography
29%
Hypokalemia
29%
Cardiovascular System
26%
Heart Left Ventricle Ejection Fraction
25%
Patient with Type 2 Diabetes
24%
Exercise
22%
Cell Function
21%
Glucagon-Like Peptide-1 Agonist
20%
Population
20%
Atrial Fibrillation
19%
Computer Assisted Tomography
19%
Myocardial Infarction
18%
Non ST Segment Elevation Myocardial Infarction
17%
Adipose Tissue
17%
Systolic Blood Pressure
16%
Spine
16%
Middle Age
16%
Heart Muscle Ischemia
16%
Aortic Valve Stenosis
16%
Quality of Life
15%
